Correction to: Nature https://doi.org/10.1038/s41586-019-0916-x, published online 06 February 2019.
In this Letter, ‘Fig. 1e’ should be ‘Fig. 1d’ in the text “By contrast, the anti-tumour response in Ythdf1−/− mice was completely abrogated in the absence of CD8+ T cells (Fig. 1e, Extended Data Fig. 2i)...”. This has been corrected online.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Han, D., Liu, J., Chen, C. et al. Author Correction: Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature 568, E3 (2019). https://doi.org/10.1038/s41586-019-1046-1
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41586-019-1046-1
This article is cited by
-
m5C RNA methylation in cancer: from biological mechanism to clinical perspectives
European Journal of Medical Research (2025)
-
FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas
Cell Death & Disease (2025)
-
Comprehensive Analysis for Predicting Prognoses and Immune Responses of m6A-Related lncRNAs in Women with Lung Adenocarcinoma
Biochemical Genetics (2024)
-
The mechanism underlying redundant functions of the YTHDF proteins
Genome Biology (2023)
-
m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma
BMC Cancer (2022)
